In CAD patients, miR-199a-5p can inhibit the expression of vasodilator-stimulated phosphoprotein (VASP), and its decreased levels are significantly associated with increased platelet reactivity after clopidogrel treatment (Hu et al., 2023). The gene discussed is VASP; the disease is coronary artery disorder.